Cargando…

Outcomes and Control Rates for I-125 Plaque Brachytherapy for Uveal Melanoma: A Community-Based Institutional Experience

Purpose. To evaluate our community-based institutional experience with plaque brachytherapy for uveal melanomas with a focus on local control rates, factors impacting disease progression, and dosimetric parameters impacting treatment toxicity. Methods and Materials. Our institution was retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wagner, Aaron, Chen, Andy, Cook, Taylor, Faber, David, Winward, Kirk, Sause, William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964762/ https://www.ncbi.nlm.nih.gov/pubmed/24734198 http://dx.doi.org/10.1155/2014/950975

Ejemplares similares

Regression patterns of uveal melanoma after iodine-125 plaque brachytherapy
por: Fang, Rui, et al.
Publicado: (2021)

Reduced blood flow by laser speckle flowgraphy after (125)I-plaque brachytherapy for uveal melanoma
por: Tamplin, Michelle R., et al.
Publicado: (2022)

Intra-operative ocular ultrasonography of iodine-125 brachytherapy plaques in patients with uveal melanoma
por: Ces, Antonio Piñeiro, et al.
Publicado: (2021)

Brachytherapy of Uveal Melanomas with Ruthenium-106 Plaques
por: Belaïd, Asma, et al.
Publicado: (2016)

(103)Pd versus (125)I ophthalmic plaque brachytherapy: preoperative comparative radiation dosimetry for 319 uveal melanomas
por: Finger, Paul T., et al.
Publicado: (2014)

Temporal Relationship Between Visual Field, Retinal and Microvascular Pathology Following (125)I-Plaque Brachytherapy for Uveal Melanoma
por: Tamplin, Michelle R., et al.
Publicado: (2021)

Annulus-shaped I-125 plaque brachytherapy for conjunctival melanoma
por: Berkowitz, Sean T., et al.
Publicado: (2022)

Analysis of local recurrence causes in uveal melanoma patients treated with (125)I brachytherapy – a single institution study
por: Kowal, Joanna, et al.
Publicado: (2019)

Regression Rate of Posterior Uveal Melanomas Following Iodine-125 Plaque Radiotherapy
por: Demirci, Hakan, et al.
Publicado: (2015)

Forty-year prognosis after plaque brachytherapy of uveal melanoma
por: Stålhammar, Gustav
Publicado: (2020)

Outcomes of I-125 brachytherapy for uveal melanomas depending on irradiation dose applied to the tumor apex – a single institution study
por: Kowal, Joanna, et al.
Publicado: (2018)

Ruthenium brachytherapy for uveal melanoma – single institution experience
por: Rospond-Kubiak, Iwona, et al.
Publicado: (2017)

Silicone Oil and Iodine-125 Brachytherapy for Uveal Melanoma in High-Risk Patients
por: Lyons, Lance J, et al.
Publicado: (2019)

Microincisional vitrectomy for retinal detachment in I-125 brachytherapy-treated patients with posterior uveal malignant melanoma
por: Lonngi, Marcela, et al.
Publicado: (2013)

(106)Ruthenium eye plaque brachytherapy in the management of medium sized uveal melanoma
por: Jiang, Ping, et al.
Publicado: (2020)

Staged Eye-Plaque Brachytherapy: A Novel Approach for Large Uveal Melanoma
por: Chevli, Neil, et al.
Publicado: (2021)

Three-year outcomes of uveal melanoma treated with intra-operative ultrasound-guided iodine-125 brachytherapy using custom-built eye plaques
por: Wong, Andrew J., et al.
Publicado: (2022)

Prognosis Prediction of Uveal Melanoma After Plaque Brachytherapy Based on Ultrasound With Machine Learning
por: Luo, Jingting, et al.
Publicado: (2022)

A Prognostic Score for the Prediction of Local Treatment Failure in Plaque Brachytherapy of Uveal Melanoma
por: Kal Omar, Ruba, et al.
Publicado: (2022)

Treatment planning considerations for (125)I eye plaque brachytherapy
por: Miguel, David, et al.
Publicado: (2019)

Nomogram for predicting radiation maculopathy in patients treated with Ruthenium-106 plaque brachytherapy for uveal melanoma
por: Tagliaferri, Luca, et al.
Publicado: (2017)

Long-Term Followup Comparing Two Treatment Dosing Strategies of (125)I Plaque Radiotherapy in the Management of Small/Medium Posterior Uveal Melanoma
por: Murray, Timothy G., et al.
Publicado: (2013)

Tumor parameters predict the risk of side effects after ruthenium-106 plaque brachytherapy of uveal melanomas
por: Tarmann, Lisa, et al.
Publicado: (2017)

Cherenkov Luminescence Imaging for Assessment of Radioactive Plaque Position in Brachytherapy of Uveal Melanoma: An In Vivo Feasibility Study
por: Krohn, Jørgen, et al.
Publicado: (2020)

A study comparing baseline and best-corrected visual acuity after iodine-125 episcleral brachytherapy in uveal melanoma
por: Miguel, David, et al.
Publicado: (2023)

Evaluation of the surgical learning curve for I-125 episcleral plaque placement for the treatment of posterior uveal melanoma: a two decade review
por: Shah, Nisha V, et al.
Publicado: (2012)

Histopathology of Intraocular Medulloepithelioma following Iodine-125 Plaque Brachytherapy
por: Mohan, Sukriti, et al.
Publicado: (2022)

Iodine-(125) plaque brachytherapy for aggressive squamous cell carcinoma with corneal and scleral invasion
por: Kaufman, Aaron R., et al.
Publicado: (2022)

Regression of posterior uveal melanoma following iodine-125 plaque radiotherapy based on pre-treatment tumor apical height
por: Miguel, David, et al.
Publicado: (2021)

Radiological and clinical findings in uveal melanoma treated by plaque interventional radiotherapy (brachytherapy): Visual atlas and literature review on response assessment
por: Fionda, Bruno, et al.
Publicado: (2022)

Longitudinal optical coherence tomography angiography (OCT-A) in a patient with radiation retinopathy following plaque brachytherapy for uveal melanoma
por: Binkley, Elaine M., et al.
Publicado: (2022)

Episcleral plaque brachytherapy using ‘BARC I-125 Ocu-Prosta seeds’ in the treatment of intraocular tumors: A single-institution experience in India
por: Shah, Parag K, et al.
Publicado: (2012)

Brachytherapy for patients with uveal melanoma: historical perspectives and future treatment directions
por: Brewington, Beatrice Y, et al.
Publicado: (2018)

Long-Term Outcomes in Uveal Melanoma After Ruthenium-106 Brachytherapy
por: Cennamo, Gilda, et al.
Publicado: (2022)

Clinical Outcomes after Surgical Resection Combined with Brachytherapy for Uveal Melanomas
por: Relimpio-López, Isabel, et al.
Publicado: (2022)

Ruthenium-106 brachytherapy for thick uveal melanoma: reappraisal of apex and base dose radiation and dose rate
por: Naseripour, Masood, et al.
Publicado: (2016)

Preliminary Results of Uveal Melanoma Treated With Iodine-125 Plaques: Analysis of Disease Control and Visual Outcomes With 63 Gy to the Target Volume
por: Kheir, Wajiha J., et al.
Publicado: (2022)

Complications and adverse events of plaque brachytherapy for ocular melanoma
por: Peddada, Krishi V., et al.
Publicado: (2019)

Characteristics, management, and outcome of patients with uveal melanoma treated by Iodine-125 radioactive plaque therapy in a single tertiary cancer center in Jordan
por: Jaradat, Imad, et al.
Publicado: (2018)

Radiobiological evaluation of organs at risk for electronic high-dose-rate brachytherapy in uveal melanoma: a radiobiological modeling study
por: Waldron, Timothy J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pumldoua7da3ca06tcp0uq0mto